NSC |
Compound |
Enrichment |
Correlation |
NSC 113497 |
16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) |
0.0147237897640499 |
0.30319305 |
NSC 126228 |
Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.0147237897640499 |
0.30634231 |
NSC 129794 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.0147237897640499 |
0.32938539 |
NSC 185065 |
Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- |
0.0147237897640499 |
0.2365469 |
NSC 244404 |
Null |
0.0147237897640499 |
0.44923778 |
NSC 303861 |
L-Cysteine analog |
0.0147237897640499 |
0.47554487 |
NSC 614887 |
Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) |
0.0147237897640499 |
0.4594518 |
NSC 617394 |
Null |
0.0147237897640499 |
0.52255914 |
NSC 649312 |
Null |
0.0147237897640499 |
0.33601128 |
NSC 651605 |
Null |
0.0147237897640499 |
0.27820311 |